Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Neurology and Neuroscience Reports
Erschienen in: Current Neurology and Neuroscience Reports 5/2019

01.05.2019 | Headache (R. Halker Singh, Section Editor)

New Daily Persistent Headache: a Diagnostic and Therapeutic Odyssey

verfasst von: Emily J. Riddle, Jonathan H. Smith

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

New daily persistent headache (NDPH) is a rare primary headache disorder, which often has a refractory clinical course. This narrative review seeks to highlight what is known about the development of NDPH, to outline a diagnostic approach to a patient with new daily headache, and to explore management considerations and potential future therapies for patients diagnosed with NDPH.

Recent Findings

Interval work at the level of case series and cohort studies has identified novel triggering factors (e.g., Valsalva), subgroups with unique temporal profiles (e.g., thunderclap onset), psychophysical profiles (e.g., increased pain catastrophizing), and potential treatment options.

Summary

The approach to the diagnosis and treatment of NDPH remains individualized, driven by clinical features and challenging in most cases. Earlier identification of patients (e.g., prediction of patients with status migrainosus destined to develop NDPH) may allow for more effective treatment.
Literatur
1.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.CrossRef
2.
Robbins MS, Evans RW. The heterogeneity of new daily persistent headache. Headache. 2012;52(10):1579–89.CrossRefPubMed
3.
4.
Castillo J, Munoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999;39(3):190–6.CrossRefPubMed
5.
Grande RB, Aaseth K, Lundqvist C, Russell MB. Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia. 2009;29(11):1149–55.CrossRefPubMed
6.
Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22(1):66–9.CrossRefPubMed
7.
Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug-based treatment, and prognosis of new daily persistent headache (NDPH): 30 cases in Japan. Cephalalgia. 2004;24(11):955–9.CrossRefPubMed
8.
Meineri P, Torre E, Rota E, Grasso E. New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci. 2004;25(Suppl 3):S281–2.CrossRefPubMed
9.
Kung E, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. New daily persistent headache in the paediatric population. Cephalalgia. 2009;29(1):17–22.CrossRefPubMed
10.
•• Rozen TD. Triggering events and new daily persistent headache: age and gender differences and insights on pathogenesis-a clinic-based study. Headache. 2016;56(1):164–73 This is a retrospective cohort demonstrating a similar age- and sex-profiles irrespective of triggering events, suggesting the possibility of common susceptibility factors. Further, patients developing NDPH following a surgical procedure are all required endotracheal intubation, suggesting cervicogenic mechanisms . CrossRefPubMed
11.
Prakash S, Saini S, Rana KR, Mahato P. Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India. J Headache Pain. 2012;13(6):477–85.CrossRefPubMedPubMedCentral
12.
Rozen TD. New daily persistent headache (NDPH) triggered by a single Valsalva event: a case series. Cephalalgia. 2018:333102418806869.
13.
Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010;74(17):1358–64.CrossRefPubMedPubMedCentral
14.
Peng KP, Fuh JL, Yuan HK, Shia BC, Wang SJ. New daily persistent headache: should migrainous features be incorporated? Cephalalgia. 2011;31(15):1561–9.CrossRefPubMed
15.
• Uniyal R, Paliwal VK, Tripathi A. Psychiatric comorbidity in new daily persistent headache: a cross-sectional study. Eur J Pain. 2017;21(6):1031–8 This is a case-control study demonstrating that anxiety, depressive symptoms, somatization, and pain catastrophizing are more prevalent in NDPH as compared with healthy and chronic back pain control groups. CrossRefPubMed
16.
Smith JH. Enduring phenotype of episodic status migrainosus in a prospectively identified patient. Cephalalgia Rep. 2018;1:2515816318815226.
17.
Rozen TD, Beams JL. New daily persistent headache with a thunderclap headache onset and complete response to nimodipine (a new distinct subtype of NDPH). J Headache Pain. 2013;14:100.CrossRefPubMedPubMedCentral
18.
Diaz-Mitoma F, Vanast WJ, Tyrrell DL. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet. 1987;1(8530):411–5.CrossRefPubMed
19.
Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol. 2004;31(2):122–5.CrossRefPubMed
20.
Rozen TD, Roth JM, Denenberg N. Cervical spine joint hypermobility: a possible predisposing factor for new daily persistent headache. Cephalalgia. 2006;26(10):1182–5.CrossRefPubMed
21.
Alexander J. Resolution of new daily persistent headache after osteopathic manipulative treatment. J Am Osteopath Assoc. 2016;116(3):182–5.CrossRefPubMed
22.
Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic daily headache: identification of factors associated with induction and transformation. Headache. 2002;42(7):575–81.CrossRefPubMed
23.
Grengs LR, Mack KJ. New daily persistent headache is most likely to begin at the start of school. J Child Neurol. 2016;31(7):864–8.CrossRefPubMed
24.
Peres MF, Lucchetti G, Mercante JP, Young WB. New daily persistent headache and panic disorder. Cephalalgia. 2011;31(2):250–3.CrossRefPubMed
25.
Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache. 2007;47(7):1050–5.CrossRefPubMed
26.
Nierenburg H, Newman LC. Update on new daily persistent headache. Curr Treat Options Neurol. 2016;18(6):25.CrossRefPubMed
27.
28.
Rozen TD. New daily persistent headache: a lack of an association with white matter abnormalities on neuroimaging. Cephalalgia. 2016;36(10):987–92.CrossRefPubMed
29.
Smith JH, Garrity JA, Boes CJ. Clinical features and long-term prognosis of trochlear headaches. Eur J Neurol. 2014;21(4):577–85.CrossRefPubMed
30.
Garza I. Images from headache: a “noisy” headache: dural arteriovenous fistula resembling new daily persistent headache. Headache. 2008;48(7):1120–1.CrossRefPubMed
31.
Rozen T, Swidan S, Hamel R, Saper J. Trendelenburg position: a tool to screen for the presence of a low CSF pressure syndrome in daily headache patients. Headache. 2008;48(9):1366–71.CrossRefPubMed
32.
Correia I, Marques IB, Ferreira R, Cordeiro M, Sousa L. Spontaneous intracranial hypotension treated with a targeted CT-guided epidural blood patch. Case Rep Med. 2016;2016:9809017.PubMedPubMedCentral
33.
34.
Rabner J, Kaczynski KJ, Simons LE, LeBel A. Pediatric headache and sleep disturbance: a comparison of diagnostic groups. Headache. 2018;58(2):217–28.CrossRefPubMed
35.
Krause SJ, Stillman MJ, Tepper DE, Zajac D. A prospective cohort study of outpatient interdisciplinary rehabilitation of chronic headache patients. Headache. 2017;57(3):428–40.CrossRefPubMed
36.
• Ali A, Kriegler J, Tepper S, Vij B. New daily persistent headache and onabotulinumtoxinA therapy. Clin Neuropharmacol. 2019;42(1):1–3 This is a small retrospective study demonstrating headache improvements in 75% of patients following 1-year of treatment. It is also our anectodal experience that this therapy may be helpful in NDPH patients, more so than other traditional chronic migraine therapies. CrossRefPubMed
37.
38.
39.
Puledda F, Goadsby PJ, Prabhakar P. Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation. J Headache Pain. 2018;19(1):5.CrossRefPubMedPubMedCentral
40.
Gelfand AA, Reider AC, Goadsby PJ. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol. 2014;50(2):135–9.CrossRefPubMed
41.
Hascalovici JR, Robbins MS. Peripheral nerve blocks for the treatment of headache in older adults: a retrospective study. Headache. 2017;57(1):80–6.CrossRefPubMed
42.
Blake P, Nir RR, Perry CJ, Burstein R. Tracking patients with chronic occipital headache after occipital nerve decompression surgery: a case series. Cephalalgia. 2018:333102418801585.
43.
Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine infusions for treatment refractory headache. Headache. 2017;57(2):276–82.CrossRefPubMed
44.
Marmura MJ, Passero FC Jr, Young WB. Mexiletine for refractory chronic daily headache: a report of nine cases. Headache. 2008;48(10):1506–10.CrossRefPubMed
45.
Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011;77(20):1827–32.CrossRefPubMed
Metadaten
Titel
New Daily Persistent Headache: a Diagnostic and Therapeutic Odyssey
verfasst von
Emily J. Riddle
Jonathan H. Smith
Publikationsdatum
01.05.2019
Verlag
Springer US
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 5/2019
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-019-0936-9

Weitere Artikel der Ausgabe 5/2019

Current Neurology and Neuroscience Reports 5/2019 Zur Ausgabe

Headache (R. Halker Singh, Section Editor)

Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management

Neuro-Ophthalmology (R. Mallery, Section Editor)

Perceptual Postural Imbalance and Visual Vertigo

Behavior (H. Kirshner, Section Editor)

Update on the Clinical Approach to Spatial Neglect

Headache (R. Halker Singh, Section Editor)

A Review of Spontaneous Intracranial Hypotension

Neurology of Systemic Diseases (J. Biller, Section Editor)

Neurological Complications of Infective Endocarditis

Neuroimaging (N. Pavese, Section Editor)

New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus
Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

19.04.2024 | AAN-Jahrestagung 2024 | Nachrichten

Hustenstiller lindert Agitation bei Alzheimer
weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise